Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,262
Active & Responsive
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Palo Alto CA, Los Angeles CA, La Jolla CA,
Sponsor: Dyne Therapeutics
Sex: All
Age: 16+
Code: NCT07486934
Phase 3, Recruiting
Active & Responsive
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
for
Relapsing Multiple Sclerosis,
Location: Palo Alto CA, Portland OR, Seattle WA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 55
Code: NCT04047628
Phase 3, Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Palo Alto CA, Lancaster CA, Loma Linda CA,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase 3, Recruiting
Active & Responsive
Study of Oral Food Challenge Biomarkers (SAFER)
for
Allergy
Location: Palo Alto CA, Little Rock AR, Chicago IL, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 1 - 17
Code: NCT07279467
Recruiting
Active & Responsive
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Palo Alto CA, Los Angeles CA, Los Alamitos CA,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase 2, Recruiting
Active & Responsive
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
Location: Palo Alto CA, San Jose CA, Woodland Hills CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07441681
Phase 3, Recruiting
Active & Responsive
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Stanford CA, Los Angeles CA, Houston TX, Detroit MI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07111520
Phase 1, Phase 2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Palo Alto CA, Clovis CA, Los Angeles CA, Duarte CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase 3, Recruiting
Active & Responsive
Gastroschisis Outcomes of Delivery (GOOD) Study
for
Gastroschisis
Location: Stanford CA, Loma Linda CA, Portland OR,
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT02774746
Recruiting
Active & Responsive
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
for
Sickle Cell Disease
Location: Palo Alto CA, Los Angeles CA, St Louis MO, Columbus OH,
Sponsor: Kamau Therapeutics
Sex: All
Age: 12 - 50
Code: NCT04819841
Phase 1, Phase 2, Recruiting
Active & Responsive
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Location: Mountain View CA, Palo Alto CA, Lehi UT,
Sponsor: University of Utah
Sex: All
Age: 0 - 18
Code: NCT05471908
Recruiting
Active & Responsive
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
for
Acute Leukemia, Myelodysplastic Syndrome
Location: Palo Alto CA
Sponsor: Laguna Biotherapeutics, Inc.
Sex: All
Age: 1 - 39
Code: NCT07573111
Phase 1, Recruiting
Active & Responsive
Studying Melatonin and Recovery in Teens
for
Juvenile; Scoliosis, Scoliosis Idiopathic,
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 12 - 18
Code: NCT06093477
Recruiting
Active & Responsive
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Redwood City CA, Orange CA, Seattle WA, Kansas City MO,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Sex: All
Age: 0 - 70+
Code: NCT05500807
Phase 1, Recruiting
Active & Responsive
Prostate Stimulation for Sexual Dysfunction
for
Sexual Dysfunction, Erectile Dysfunction, Delayed Ejaculation,
Location: Stanford CA
Sponsor: Stanford University
Sex: Male
Age: 18+
Code: NCT05468931
Recruiting
Active & Responsive
Double-S: a Wearable Device for Erectile Dysfunction
for
Erectile Dysfunction
Location: Stanford CA
Sponsor: Stanford University
Sex: Male
Age: 18+
Code: NCT05451563
Recruiting
Active & Responsive
BlossomĀ® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction
for
Tissue Expansion, Implant Based Breast Reconstruction